Poland· PL-100482957

Vafseo

A vadadustat product containing vadadustatum, registered in Poland by Medice Arzneimittel Puetter GmbH & Co. KG. The same ATC class is registered in 13 of our 19 countries.

ATC B03XA08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVafseoATCB03XA08REGISTER NO.PL-100482957PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Vadadustat is registered in 13 of 19 countries.

Countries holding a registration under ATC B03XA08 (vadadustat), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Vadadustat · ATC B03XA08

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vadadustat costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vadadustat · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$15.64
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Vadadustatum
Manufacturer
Medice Arzneimittel Puetter GmbH & Co. KG
Country
Poland (PL)
ATC code
B03XA08
ATC class
Vadadustat
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/04144297-7a0c-4776-a9b7-549fb457d37e
GET /v1/drugs/04144297-7a0c-4776-a9b7-549fb457d37e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "450 mg",
  "packaging": "Rpz ¦ EU/1/23/1725/005 ¦ 150057\n28 tabl.\nRpz ¦ EU/1/23/1725/006 ¦ 150058\n98 tabl.",
  "substance": "Vadadustatum 450 mg",
  "common_name": "Vadadustatum",
  "pl_product_id": "100482957",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about vadadustat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.